(Q37950331)

English

Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?

scientific article published on 27 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

0 references

magnetic resonance imaging

0 references

author name string

Mustafa R Bashir

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Daniela B Husarik

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Tim J Ziemlewicz

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Rajan T Gupta

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Daniel T Boll

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Elmar M Merkle

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

27 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

611-616

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Advanced MRI methods for assessment of chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatoce

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Consensus report of the 2nd International Forum for Liver MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Identifiers

10.1002/JMRI.22850

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37950331&oldid=1406268164"